BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29186980)

  • 1. Overexpressed miR-128a enhances chemoradiotherapy to laryngeal cancer cells and its correlation with BMI1.
    Chen H; Jin L; Zhou L; Huang JM
    Future Oncol; 2018 Mar; 14(7):611-620. PubMed ID: 29186980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulating hsa-miR-128a Increased the Effects of Pembrolizumab on Laryngeal Cancer Cells via the p53 Pathway.
    Chen H; Guo Y; Huang J; Zhou L
    Biomed Res Int; 2021; 2021():2342784. PubMed ID: 33791361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA‑128a, BMI1 polycomb ring finger oncogene, and reactive oxygen species inhibit the growth of U‑87 MG glioblastoma cells following exposure to X‑ray radiation.
    Ye L; Yu G; Wang C; Du B; Sun D; Liu J; Qi T; Yu X; Wei W; Cheng J; Jiang Y
    Mol Med Rep; 2015 Oct; 12(4):6247-54. PubMed ID: 26238021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
    Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J
    J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of DGCR5 enhances the radiosensitivity of human laryngeal carcinoma cells via inducing miR-195.
    Tang T; Shan G; Zeng F
    J Cell Physiol; 2019 Aug; 234(8):12918-12925. PubMed ID: 30549038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.
    Dimri M; Kang M; Dimri GP
    Oncotarget; 2016 Jun; 7(24):36220-36234. PubMed ID: 27105531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-503 enhances the radiosensitivity of laryngeal carcinoma cells via the inhibition of WEE1.
    Ma H; Lian R; Wu Z; Li X; Yu W; Shang Y; Guo X
    Tumour Biol; 2017 Oct; 39(10):1010428317706224. PubMed ID: 29019284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1.
    Patel N; Garikapati KR; Ramaiah MJ; Polavarapu KK; Bhadra U; Bhadra MP
    Life Sci; 2016 Nov; 164():60-70. PubMed ID: 27596816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
    Gergely JE; Dorsey AE; Dimri GP; Dimri M
    Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of miR-145 in human laryngeal squamous cell carcinoma.
    Karatas OF; Yuceturk B; Suer I; Yilmaz M; Cansiz H; Solak M; Ittmann M; Ozen M
    Head Neck; 2016 Feb; 38(2):260-6. PubMed ID: 26083661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1.
    Chang X; Sun Y; Han S; Zhu W; Zhang H; Lian S
    Biochem Biophys Res Commun; 2015 Jan; 456(1):361-6. PubMed ID: 25475727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of MiR-203a Disinhibits Bmi1 and Promotes Growth and Proliferation of Keratinocytes in Cholesteatoma.
    Zang J; Hui L; Yang N; Yang B; Jiang X
    Int J Med Sci; 2018; 15(5):447-455. PubMed ID: 29559833
    [No Abstract]   [Full Text] [Related]  

  • 13. A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells.
    Yin J; Zheng G; Jia X; Zhang Z; Zhang W; Song Y; Xiong Y; He Z
    PLoS One; 2013; 8(9):e73268. PubMed ID: 24039897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.
    Luo H; Yang R; Li C; Tong Y; Fan L; Liu X; Xu C
    Tumour Biol; 2017 Jul; 39(7):1010428317718414. PubMed ID: 28720065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells.
    Weng JH; Yu CC; Lee YC; Lin CW; Chang WW; Kuo YL
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMI1'S maintenance of the proliferative capacity of laryngeal cancer stem cells.
    Chen H; Zhou L; Dou T; Wan G; Tang H; Tian J
    Head Neck; 2011 Aug; 33(8):1115-25. PubMed ID: 21755556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Andrographolide impedes cancer stemness and enhances radio-sensitivity in oral carcinomas via miR-218 activation.
    Yang PY; Hsieh PL; Wang TH; Yu CC; Lu MY; Liao YW; Lee TH; Peng CY
    Oncotarget; 2017 Jan; 8(3):4196-4207. PubMed ID: 27926533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-203 inhibits cell growth and regulates G1/S transition by targeting Bmi-1 in myeloma cells.
    Wu SQ; Niu WY; Li YP; Huang HB; Zhan R
    Mol Med Rep; 2016 Nov; 14(5):4795-4801. PubMed ID: 27748826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.
    Griffith J; Andrade D; Mehta M; Berry W; Benbrook DM; Aravindan N; Herman TS; Ramesh R; Munshi A
    Oncol Rep; 2017 Apr; 37(4):2382-2390. PubMed ID: 28260023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of miR-30e* regulation of Bmi1 expression mediated by tumor-associated macrophages in gastrointestinal cancer.
    Sugihara H; Ishimoto T; Watanabe M; Sawayama H; Iwatsuki M; Baba Y; Komohara Y; Takeya M; Baba H
    PLoS One; 2013; 8(11):e81839. PubMed ID: 24312366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.